title: Balance of Benefit and Risk in Intravenous Iron Treatment in Chronic Kidney Disease.
abstract: Iron supplementation is an important aspect of treatment for hemodialysis patients, with most administration by an intravenous route. As with any drug, decisions as to treatment are most meaningful when benefits and risks are weighed in the context of the individual patient's clinical characteristics. In this article, knowledge of benefits and risks of intravenous iron are reviewed.
authors.affiliation: Department of Medicine, Division of Nephrology, Hofstra North Shore-LIJ School of Medicine, Great Neck, NY. Electronic address: sfishbane@nshs.edu.
authors.forename: Steven
authors.initials: S
authors.lastname: Fishbane
mesh_terms: D061605:Administration, Intravenous; D000707:Anaphylaxis / Q000139:chemically induced; D018798:Anemia, Iron-Deficiency / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D006397:Hematinics / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D058085:Iron Compounds / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000378:metabolism*; D018570:Risk Assessment
chemical_list: D006397:Hematinics; D058085:Iron Compounds
keywords: Anemia; drug safety; iron deficiency; iron treatment